Clinical Trial Update: Clinical Trial to Demonstrate the Effectiveness of Fecal Microbiota Transplantation for Selective Intestinal Decolonization of Patients Colonized by Carbapenemase-producing Klebsiella Pneumoniae [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fecal microbiota transplantation to decolonize patients carrying carbapenemase-producing Klebsiella pneumoniae has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carbapenemase-producing Enterobacteriaceae Infection
• Klebsiella Pneumoniae Infection

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Maimónides Biomedical Research Institute of Córdoba | Conditions: Carbapenemase-producing Enterobacteriaceae Infection | Phase 2 | Status: TERMINATED